A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Trial details
- Registry ID
- NCT07218146
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)NCT07218146 | Zai Lab (Shanghai) Co., Ltd. | Phase 3 | Recruiting | 2028-06-30Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |